BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32589760)

  • 1. Attenuated early inflammatory response in solid organ recipients with COVID-19.
    Bösch F; Börner N; Kemmner S; Lampert C; Jacob S; Koliogiannis D; Stangl M; Michel S; Kneidinger N; Schneider C; Fischereder M; Irlbeck M; Denk G; Werner J; Angele MK; Guba MO
    Clin Transplant; 2020 Oct; 34(10):e14027. PubMed ID: 32589760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart transplant recipients with confirmed 2019 novel coronavirus infection: The Detroit experience.
    Al-Darzi W; Aurora L; Michaels A; Cowger J; Grafton G; Selektor Y; Tita C; Hannawi B; Lanfear D; Nemeh HW; Williams CT
    Clin Transplant; 2020 Dec; 34(12):e14091. PubMed ID: 32940925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 pneumonia in kidney transplant recipients: Focus on immunosuppression management.
    Chen TY; Farghaly S; Cham S; Tatem LL; Sin JH; Rauda R; Ribisi M; Sumrani N
    Transpl Infect Dis; 2020 Oct; 22(5):e13378. PubMed ID: 32573882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 in solid organ transplant recipients: Dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients.
    Roberts MB; Izzy S; Tahir Z; Al Jarrah A; Fishman JA; El Khoury J
    Transpl Infect Dis; 2020 Oct; 22(5):e13407. PubMed ID: 32654303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proposed strategy for management of immunosuppression in heart transplant patients with COVID-19.
    Ahluwalia M; Givertz MM; Mehra MR
    Clin Transplant; 2020 Nov; 34(11):e14032. PubMed ID: 32621523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pediatric solid organ transplant experience with COVID-19: An initial multi-center, multi-organ case series.
    Goss MB; Galván NTN; Ruan W; Munoz FM; Brewer ED; O'Mahony CA; Melicoff-Portillo E; Dreyer WJ; Miloh TA; Cigarroa FG; Ranch D; Yoeli D; Adams MA; Koohmaraie S; Harter DM; Rana A; Cotton RT; Carter B; Patel S; Moreno NF; Leung DH; Goss JA
    Pediatr Transplant; 2021 May; 25(3):e13868. PubMed ID: 32949098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 infection in kidney transplant recipients: Experience of the italian marche region.
    Maritati F; Cerutti E; Zuccatosta L; Fiorentini A; Finale C; Ficosecco M; Cristiano F; Capestro A; Balestra E; Taruscia D; Vivarelli M; Donati A; Perna GP; Giacometti A; Tavio M; Onesta M; Di Sante L; Ranghino A
    Transpl Infect Dis; 2020 Oct; 22(5):e13377. PubMed ID: 32573895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul.
    Demir E; Uyar M; Parmaksiz E; Sinangil A; Yelken B; Dirim AB; Merhametsiz O; Yadigar S; Atan Ucar Z; Ucar AR; Demir ME; Mese M; Akin EB; Garayeva N; Safak S; Oto OA; Yazici H; Turkmen A
    Transpl Infect Dis; 2020 Oct; 22(5):e13371. PubMed ID: 32657540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental COVID-19 in a heart-kidney transplant recipient with malnutrition and recurrent infections: Implications for the SARS-CoV-2 immune response.
    Serrano OK; Kutzler HL; Rochon C; Radojevic JA; Lawlor MT; Hammond JA; Gluck J; Feingold AD; Jaiswal A
    Transpl Infect Dis; 2020 Dec; 22(6):e13367. PubMed ID: 32533615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The COVID-19 pandemic: A community approach.
    Cravedi P; Schold JD; Safa K; Kates OS; Elfadawy N; Mannon RB; Shah MB; Hammond SP; Avery R; Guerrero Miranda C; Riella LV; Jowsey-Gregoire S; Akalin E; Camirand G; Alegre ML; Azzi J
    Clin Transplant; 2020 Nov; 34(11):e14059. PubMed ID: 32762055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: Initial experience at a single center in Madrid, Spain.
    Loinaz C; Marcacuzco A; Fernández-Ruiz M; Caso O; Cambra F; San Juan R; Justo I; Calvo J; García-Sesma A; Manrique A; Pérez-Jacoiste Asín MA; Folgueira MD; Aguado JM; Lumbreras C
    Transpl Infect Dis; 2020 Oct; 22(5):e13372. PubMed ID: 32562561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2-specific Cell-mediated Immunity in Kidney Transplant Recipients Recovered From COVID-19.
    Fernández-Ruiz M; Olea B; Giménez E; Laguna-Goya R; Trujillo H; Caravaca-Fontán F; Gutiérrez E; López-Medrano F; Remigia MJ; Almendro-Vazquez P; Polanco N; González E; Ruiz-Merlo T; Parra P; San Juan R; Andrés A; Navarro D; Aguado JM
    Transplantation; 2021 Jun; 105(6):1372-1380. PubMed ID: 33729741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of immunocompromised COVID-19 patients with convalescent plasma.
    Fung M; Nambiar A; Pandey S; Aldrich JM; Teraoka J; Freise C; Roberts J; Chandran S; Hays SR; Bainbridge E; DeVoe C; Roque Gardner A; Yokoe D; Henrich TJ; Babik JM; Chin-Hong P
    Transpl Infect Dis; 2021 Apr; 23(2):e13477. PubMed ID: 32989856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy.
    Patrono D; Lupo F; Canta F; Mazza E; Mirabella S; Corcione S; Tandoi F; De Rosa FG; Romagnoli R
    Transpl Infect Dis; 2020 Oct; 22(5):e13353. PubMed ID: 32500942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease.
    Scharrer S; Kutschera M; Weseslindtner L; Primas C; Vogelsang H
    Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):443-447. PubMed ID: 33522752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low rate of COVID-19 pneumonia in kidney transplant recipients-A battle between infection and immune response?
    Ghaffari Rahbar M; Nafar M; Khoshdel A; Dalili N; Abrishami A; Firouzan A; Poorrezagholi F; Samadian F; Ziaie S; Fatemizadeh S; Samavat S
    Transpl Infect Dis; 2020 Oct; 22(5):e13406. PubMed ID: 32654357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The case of a liver-transplant recipient with severe acute respiratory syndrome coronavirus 2 infection who had a favorable outcome.
    Hayashi K; Ito Y; Yamane R; Yoshizaki M; Matsushita K; Kajikawa G; Kozawa T; Mizutani T; Shimizu Y; Nagano K; Tachi K; Yoshioka K; Goto H
    Clin J Gastroenterol; 2021 Jun; 14(3):842-845. PubMed ID: 33675512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient management of kidney transplant recipients with suspected COVID-19-Single-center experience during the New York City surge.
    Mehta SA; Leonard J; Labella P; Cartiera K; Soomro I; Neumann H; Montgomery RA; Ali NM
    Transpl Infect Dis; 2020 Dec; 22(6):e13383. PubMed ID: 32578324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Belatacept, kidney transplantation and COVID-19: Successful management of the first reported case within the United Kingdom.
    Ahmad SH; Smith R; Camilleri B
    Clin Transplant; 2020 Sep; 34(9):e14026. PubMed ID: 32603010
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical course of COVID-19 disease in immunosuppressed renal transplant patients.
    Dheir H; Sipahi S; Yaylacı S; Çetin ES; Genç AB; Fırat N; Köroğlu M; Muratdağı G; Tomak Y; Özmen K; Ateş ÖF; Karabay O
    Turk J Med Sci; 2021 Apr; 51(2):428-434. PubMed ID: 33185367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.